Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
Rheumatologists, with their musculoskeletal background, often care for athletes. The effect of a positive anti-doping test, whether through illegitimate use or accidental prescribing of banned drugs, is devastating to an athlete's career. It is therefore incumbent upon rheumatologists to be aware of issues relating to drugs in sport. This involves both therapeutic drugs and doping. It is vital to ensure that any substance prescribed should be approved for use and should not adversely affect (or benefit) the athlete's performance. In March 2004, 5 months prior to the 2004 Olympic Games in Athens, the joint World Anti-Doping Agency/International Olympic Committee published the revised list of banned substances in athletes. This article aims to provide an overview of the current status of medications commonly prescribed in rheumatological practice.
Smith
R
R
New South Wales Institute of Sports Medicine and Department of Rheumatology, Concord Hospital, NSW 2139, Australia.
Barnsley
L
L
Kannangara
S
S
Mace
A
A
D018501:Antirheumatic Agents / Q000008:administration & dosage*; D004300:Doping in Sports / Q000331:legislation & jurisprudence* / Q000517:prevention & control; D011307:Drug Prescriptions; D004335:Drug and Narcotic Control; D006801:Humans; D007391:International Cooperation; D017410:Practice Guidelines as Topic; D015813:Substance Abuse Detection / Q000379:methods
D018501:Antirheumatic Agents